Inventor · disambiguated record
Stephen W. Kaldor
Also filed as: KALDOR STEPHEN · KALDOR STEPHEN W · KALDOR STEPHEN WARREN · REICH SIEGFRIED H
95 granted patents·22 pending applications·941 citations·filing 1992–2025
99Inventor score
Files withLILLY CO ELI20CELGENE QUANTICEL RES INC17KINNATE BIOPHARMA INC17TAKEDA PHARMACEUTICAL14XINTHERA INC14
Top patents by PatentIndex Score
117 records- 0198US9255097B2Inhibitors of lysine specific demethylase-1QUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted Feb 9, 2016·29 cites·30 claims
- 0298US5484926AHIV protease inhibitorsAGOURON PHARMA·Filed 1994·Granted Jan 16, 1996·158 cites·8 claims
- 0397US10927111B2Inhibitors of RAF kinasesKINNATE BIOPHARMA INC·Filed 2020·Granted Feb 23, 2021·9 cites·29 claims
- 0496US11795173B1Substituted pyridines as PARP1 inhibitorsXINTHERA INC·Filed 2023·Granted Oct 24, 2023·5 cites·18 claims
- 0596US11591331B2PARP1 inhibitors and uses thereofXINTHERA INC·Filed 2022·Granted Feb 28, 2023·6 cites·21 claims
- 0696US11407737B2Inhibitors of RAF kinasesKINNATE BIOPHARMA INC·Filed 2021·Granted Aug 9, 2022·8 cites·30 claims
- 0796US11098031B1Inhibitors of RAF kinasesKINNATE BIOPHARMA INC·Filed 2020·Granted Aug 24, 2021·12 cites·30 claims
- 0896US11084793B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2020·Granted Aug 10, 2021·3 cites·24 claims
- 0996US11053219B2Substituted pyridines as TYK2 inhibitorsFRONTHERA U S PHARMACEUTICALS LLC·Filed 2020·Granted Jul 6, 2021·9 cites·57 claims
- 1096US9573930B2Inhibitors of lysine specific demethylase-1QUANTICEL PHARMACEUTICALS INC·Filed 2016·Granted Feb 21, 2017·15 cites·16 claims
- 1195US12006322B2Substituted pyridines as PARP1 inhibitorsXINTHERA INC·Filed 2023·Granted Jun 11, 2024·2 cites·4 claims
- 1295US11680056B2MK2 inhibitors and uses thereofXINTHERA INC·Filed 2022·Granted Jun 20, 2023·3 cites·28 claims
- 1395US11377431B2Inhibitors of RAF kinasesKINNATE BIOPHARMA INC·Filed 2021·Granted Jul 5, 2022·7 cites·30 claims
- 1495US11345681B1Inhibitors of fibroblast growth factor receptor kinasesKINNATE BIOPHARMA INC·Filed 2021·Granted May 31, 2022·4 cites·19 claims
- 1594US11802128B2Azetidine and pyrrolidine PARP1 inhibitors and uses thereofXINTHERA INC·Filed 2023·Granted Oct 31, 2023·3 cites·15 claims
- 1694US11685719B2Pyridinone MK2 inhibitors and uses thereofXINTHERA INC·Filed 2022·Granted Jun 27, 2023·3 cites·30 claims
- 1794US9034900B2Bromodomain inhibitorsQuanticel Pharmaceuticals·Filed 2014·Granted May 19, 2015·36 cites·30 claims
- 1893US11939329B2PARP1 inhibitors and uses thereofXINTHERA INC·Filed 2023·Granted Mar 26, 2024·2 cites·5 claims
- 1993US10316016B2Compositions comprising an inhibitor of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2018·Granted Jun 11, 2019·4 cites·8 claims
- 2092US11731956B2Substituted 1,2,4-triazoles as intermediates in the synthesis of TYK2 inhibitorsALUMIS INC·Filed 2022·Granted Aug 22, 2023·1 cites·2 claims
- 2192US10047069B2Compositions comprising an inhibitor of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2017·Granted Aug 14, 2018·4 cites·3 claims
- 2291US12312336B2Inhibitors of RAF kinasesPF MEDICAMENT·Filed 2021·Granted May 27, 2025·2 cites·20 claims
- 2391US10894788B2Inhibitors of cyclin-dependent kinasesKINNATE BIOPHARMA INC·Filed 2019·Granted Jan 19, 2021·5 cites·29 claims
- 2491US9771329B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2016·Granted Sep 26, 2017·6 cites·19 claims
- 2591US8138168B1Renin inhibitorsJONES BENJAMIN·Filed 2008·Granted Mar 20, 2012·23 cites·90 claims
- 2690US10703739B2Compositions comprising an inhibitor of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2019·Granted Jul 7, 2020·2 cites·11 claims
- 2790US10654810B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2018·Granted May 19, 2020·2 cites·19 claims
- 2890US10023543B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2017·Granted Jul 17, 2018·4 cites·2 claims
- 2989US11746095B2Inhibtors of RAF kinasesKINNATE BIOPHARMA INC·Filed 2022·Granted Sep 5, 2023·1 cites·10 claims
- 3089US9776974B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2017·Granted Oct 3, 2017·4 cites·19 claims
- 3189US5863950AHIV protease inhibitorsAGOURON PHARMA·Filed 1994·Granted Jan 26, 1999·44 cites·141 claims
- 3289US5708008A5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-and 3-(piperidin-4-yl)-1H-indoles: new 5-HT1F agonistsLILLY CO ELI·Filed 1996·Granted Jan 13, 1998·80 cites·28 claims
- 3388US9828358B2Compositions comprising an inhibitor of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2016·Granted Nov 28, 2017·5 cites·20 claims
- 3488US7470700B2Dipeptidyl peptidase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2004·Granted Dec 30, 2008·23 cites·31 claims
- 3587US12006306B2Substituted pyridazines as TYK2 inhibitorsALUMIS INC·Filed 2021·Granted Jun 11, 2024·1 cites·16 claims
- 3687US7642275B2Histone deacetylase inhibitorsTAKEDA SAN DIEGO INC·Filed 2005·Granted Jan 5, 2010·12 cites·19 claims
- 3786US11667634B2Inhibitors of RAF kinasesKINNATE BIOPHARMA INC·Filed 2021·Granted Jun 6, 2023·1 cites·8 claims
- 3886US10207999B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2017·Granted Feb 19, 2019·2 cites·2 claims
- 3986US6204260B1Non-peptidyl vasopressin V1a antagonistsLILLY CO ELI·Filed 1997·Granted Mar 20, 2001·62 cites·12 claims
- 4086US5827891AHIV protease inhibtorsAGOURON PHARMA·Filed 1995·Granted Oct 27, 1998·36 cites·12 claims
- 4185US12421241B2Substituted pyridines as PARP1 inhibitorsXINTHERA INC·Filed 2024·Granted Sep 23, 2025·0 cites·4 claims
- 4285US12351572B2Substituted 1,2,4-triazoles as TYK2 inhibitorsALUMIS INC·Filed 2023·Granted Jul 8, 2025·0 cites·7 claims
- 4385US10807982B2Bromodomain inhibitorsCELGENE QUANTICEL RES INC·Filed 2019·Granted Oct 20, 2020·2 cites·14 claims
- 4485US9908885B2Bromodomain inhibitorsCELGENE QUANTICEL RES INC·Filed 2016·Granted Mar 6, 2018·4 cites·24 claims
- 4585US7550590B2Dipeptidyl peptidase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2004·Granted Jun 23, 2009·20 cites·16 claims
- 4684US5508407ARetroviral protease inhibitorsLILLY CO ELI·Filed 1992·Granted Apr 16, 1996·27 cites·30 claims
- 4783US8318727B2Polo-like kinase inhibitorsCAO SHELDON X·Filed 2010·Granted Nov 27, 2012·13 cites·13 claims
- 4883US5434265AInhibitors of HIV proteaseLILLY CO ELI·Filed 1992·Granted Jul 18, 1995·22 cites·9 claims
- 4982US11987574B2MK2 inhibitors and uses thereofXINTHERA INC·Filed 2023·Granted May 21, 2024·0 cites·22 claims
- 5082US10385051B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2018·Granted Aug 20, 2019·2 cites·45 claims
Showing the top 50 of 117 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stephen W. Kaldor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →